Journal of Gastrointestinal and Abdominal Radiology

LinksSchließen

Referenz

Eisenberg BL, Harris J, Blanke CD. et al.
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

J Surg Oncol 2009;
99 (01) 42-47

Bibliographische Angaben herunterladen

Aufrufen in: